Insider & Political Trading

Official filings, normalized for faster research

Previous-day view · Mon Sep 14 close. You are previewing the previous trading day. Subscribe to see today live and every other date — plans start at Delta, $39/mo. Sign up Sign in

Desk brief

AI Sep 14

The tape was heavily sell-skewed: 473 filings reported about $154.2M bought versus $745.9M sold, with only one congressional disclosure.

Two insider buying clusters — Cluster buying led the notable signals: four insiders bought roughly $671.5K of PMTS across four filers, while four bought about $992.1K of GPUS across four filers. PMTS GPUS

Multiple insider selling clusters — Selling clusters were broader and larger, including five insiders selling about $18.6M of CHYM, four selling $17.4M of DBX, seven selling $9.2M of COST, three selling $2.1M of IOT, and 11 selling $2.2M of LOGI. CHYM DBX COST IOT LOGI

Cascade added heavily to RSG — Cascade Investment, L.l.c. bought roughly $453.0M of RSG and was also flagged as a 10% owner adding about $453.4M. RSG was the most bought ticker over 14 days at about $695.1M from one filer. RSG L.l.c. Cascade Investment

Largest reported purchase — Over the past 14 days, Bluearc Capital Management, Llc reported the largest purchase at roughly $99.4M of PBLSX. The broader period remained sell-heavy, with about $1.4B bought versus $13.0B sold. PBLSX Llc Bluearc Capital Management

The filings to keep on the tape were the four-filer buying clusters in PMTS and GPUS versus the larger insider selling clusters in CHYM, DBX, COST, IOT, and LOGI. YPF remained the most sold ticker over 14 days at about $5.3B across 22 filers, followed by APGE at about $1.1B across nine filers.

AI-generated from the filings on this page — not financial advice.

Filings · Sep 14

1039

Latest about 10 hours ago

Disclosed buying · 14d

$1.37B

1080 purchases across 1465 tickers

Disclosed selling · 14d

$12.97B

6075 sales and dispositions

Tape lean · 14d

Heavy selling

Largest buy: PBLSX $99.38M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings

Most bought

Most sold

Signals

Fixed rules over the last 21 days — see each card for why it fired

Cluster selling CHYM

7 insiders sold $209.03M about 10 hours ago

Cluster selling PMTS

9 insiders sold $55.22M about 11 hours ago

Cluster selling DK

9 insiders sold $3.34M about 11 hours ago

Cluster selling ROIV

7 insiders sold $9.26M about 11 hours ago

Cluster selling PCOR

5 insiders sold $8.15M about 12 hours ago

Cluster selling THC

4 insiders sold $37.02M about 12 hours ago

Cluster buying PMTS

5 insiders bought $11.96M about 12 hours ago

$1M+ insider buy PMTS

Tricor Pmt25 Holdings Inc. bought $11.29M about 12 hours ago

10% owner adding PMTS

Tricor Pmt25 Holdings Inc. added $11.29M about 12 hours ago

Executive buy DVN

Gaspar Clay M bought $199.88K about 13 hours ago

Cluster buying GPUS

4 insiders bought $1.14M about 13 hours ago

Cluster selling FIGR

3 insiders sold $20.39M about 13 hours ago

Disclosure sentiment

Who is buying against who is selling · 90 days · −100 to +100

Accumulation

AMR 26 buys · 0 sells +100

AAT 17 buys · 0 sells +100

RCG 52 buys · 0 sells +100

SUJA 22 buys · 0 sells +100

DLHC 43 buys · 0 sells +100

UUU 32 buys · 0 sells +100

Distribution

UTHR 0 buys · 496 sells -100

CRWV 0 buys · 785 sells -100

DELL 0 buys · 651 sells -100

SE 0 buys · 468 sells -100

NET 0 buys · 277 sells -100

STX 0 buys · 240 sells -100

Bullish and bearish sectors

Net disclosed value · 30 days

Buying extends right, selling left. A company in more than one industry counts in each.

642 filings

Official insider and political disclosure transactions
Filed	Transaction	Issuer / asset	Reporting person	Qty / price	Value	Source
Sep 14, 2026 5-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Employee Stock Option (Right to Buy) on Commo...	Aslan Fred Insider Chief Executive Officer	155,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 10, 2026 Common Stock			45,000 shares @ $0 Direct ownership	$0
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Ra Capital Management, L.p. Insider Director / Ten Percent Owner	16,250 shares @ $0 Indirect ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Disposition Sep 10, 2026	IOT Samsara Inc. Class A Common Stock	Phillips Dominic Insider See Remarks	8,324 shares @ $38.65 Direct ownership	$321.72K	SEC Form 4
Sep 14, 2026 4-day lag	Disposition Sep 10, 2026	IOT Samsara Inc. Class A Common Stock	Kirchhoff Benjamin Louis Insider Chief Accounting Officer	3,651 shares @ $38.65 Direct ownership	$141.11K	SEC Form 4
Sep 14, 2026 4-day lag	Disposition Sep 10, 2026	IOT Samsara Inc. Class A Common Stock	Eltoukhy Adam Insider See Remarks	9,602 shares @ $38.65 Direct ownership	$371.12K	SEC Form 4
Sep 14, 2026 3-day lag	Award Sep 11, 2026	GWRE Guidewire Software, Inc. Common Stock	Cooper Jeffrey Elliott Insider Chief Financial Officer	18,650 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 11, 2026 Performance Shares on Common Stock			18,650 shares @ $0 Direct ownership	$0
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Stoppel Laura Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Sorg Elaine K. Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Hougen Elizabeth L Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Daniels Brian Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Baker Daniel G. Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Disposition Sep 10, 2026	SMTC Semtech Corp Common Stock	Green Jason Elliot Insider EVP And Cco	989 shares @ $163.94 Direct ownership	$162.14K	SEC Form 4
Same filing as the row above	Exercise Sep 10, 2026 Restricted Stock Unit on Common Stock			2,511 shares @ $0 Direct ownership	$0
Same filing as the row above	Exercise Sep 10, 2026 Common Stock			2,511 shares @ $0 Direct ownership	$0
Sep 14, 2026 4-day lag	Award Sep 10, 2026	ARTV Artiva Biotherapeutics, Inc. Director Stock Option (Right to Buy) on Commo...	Moore Alison Insider Director	16,250 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 14, 2026 4-day lag	Buy Sep 10, 2026	MAIA Maia Biotechnology, Inc. Common Stock	Guerrero Ramiro Insider Director	37,595 shares @ $1.32 Direct ownership	$49.52K	SEC Form 4
Sep 11, 2026 2-day lag	Sale Sep 9, 2026	HNGE Hinge Health, Inc. Class A Common Stock	Robinson Elliott Insider Director	0 shares @ $0 Indirect ownership	$0	SEC Form 4
Sep 11, 2026 2-day lag	Award Sep 9, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Miralles Gines Diego Insider President & Head Of R&d	45,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 9, 2026 Employee Stock Option (Right to Buy) on Common Stock			135,000 shares @ $0 Direct ownership	$0
Sep 11, 2026 2-day lag	Award Sep 9, 2026	ARTV Artiva Biotherapeutics, Inc. Employee Stock Option (Right to Buy) on Commo...	Horan Christopher Insider Chief Tech Operations Officer	120,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 9, 2026 Common Stock			40,000 shares @ $0 Direct ownership	$0
Sep 11, 2026 2-day lag	Award Sep 9, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Bush Jennifer Insider COO, CLO, Compliance Officer	45,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 9, 2026 Employee Stock Option (Right to Buy) on Common Stock			135,000 shares @ $0 Direct ownership	$0

Aslan Fred Insider Chief Executive Officer

Award

ARTV Artiva Biotherapeutics, Inc.

Calculated transaction value

Traded

Sep 10, 2026

Filed

Sep 14, 2026

Quantity / price

155,000 shares @ $0

SEC Form 4